Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
Roadmap to Rapid Sterility Testing
17 Oct 2025 -
The New Vaginal SELF FLOQSwabs® SensiGrip™
16 Oct 2025
MICROBIOLOGY EVENTS
-
LIMS Launchpad Webinar Series - Episode #4 – The Vendor Interaction
23 Oct 2025 -
Monitoring the Food Production Environment Using Real-time Total Viable Counts
23 Oct 2025 -
Rapid Methods Europe (RME) 2025
27 Oct 2025 -
PDA Pharmaceutical Microbiology Conference 2025
27 Oct 2025 -
Lab Innovations
29 Oct 2025 -
Engineering Microbes and Microbial Communities for Sustainable Bioproduction
4 Nov 2025 -
The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology
5 Nov 2025 -
AMP2025
11 Nov 2025 -
Growth Direct® Day 2025
12 Nov 2025 -
MEDICA 2025
17 Nov 2025